Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 1, 2010, Pages 229-237

  Freise, Kevin J ^a   Widness, John A ^b   Veng Pedersen, Peter ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ARTICLE; BLOOD; BLOOD SAMPLING; BLOOD VOLUME; BODY WEIGHT; CHILD GROWTH; CLINICAL ARTICLE; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; GESTATIONAL AGE; HUMAN; IN VIVO STUDY; INFANT; LOW BIRTH WEIGHT; MALE; PHARMACODYNAMICS; PHLEBOTOMY; PREMATURITY; PRIORITY JOURNAL;

BIRTH WEIGHT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; GESTATIONAL AGE; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; MODELS, BIOLOGICAL; PHLEBOTOMY; RESPIRATION, ARTIFICIAL;

EID: 73949137315     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.159905     Document Type: Article

References (40)

1. Anderson BJ and Holford NH (2009) Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 24:25-36.
2. Arbuckle TE, Wilkins R, and Sherman GJ (1993) Birth weight percentiles by gestational age in Canada. Obstet Gynecol 81:39-48.
3. Bard H and Widness JA (1997) The life span of erythrocytes transfused to preterm infants. Pediatr Res 42:9-11.
4. Brown MS (1988) Physiologic anemia of infancy: normal red-cell values and physiology of neonatal erythropoiesis, in Developmental and Neonatal Hematology (Stockman JA 3rd and Pochedly C eds), Raven Press, New York.
5. Brugnara C and Platt OS (2003) The neonatal erythrocyte and its disorders, in Nathan and Oski's Hematology of Infancy and Childhood (Nathan DG, Orkin SH, Ginsburg D, and Look AT eds) pp 19-55, W.B. Saunders Company, Philadelphia, PA.
6. Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R, Trail G, Lin FK, Browne JK, and Hines DK (1986) Characterization and biological effects of recombinant human erythropoietin. Immunobiology 172:213-224.
7. Freise KJ, Schmidt RL, Gingerich EL, Veng-Pedersen P, and Widness JA (2009) The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over time. Int J Lab Hematol 31:496-504.
8. Freise KJ, Widness JA, Schmidt RL, and Veng-Pedersen P (2007) Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep. J Pharmacokinet Pharmacodyn 34:519-547.
9. Freise KJ, Widness JA, Schmidt RL, and Veng-Pedersen P (2008) Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep. J Pharmacokinet Pharmacodyn 35:285-323.
10. Galel SA and Fontaine MJ (2006) Hazards of neonatal blood transfusion. Neoreviews 7:e69-e75.
11. Garby L, Sjoelin S, and Vuille JC (1963) Studies on erythro-kinetics in infancy. III. Disappearance from plasma and red-cell uptake of radio-active iron injected intravenously. Acta Paediatr 52:537-553.
12. Hess JR, Hill HR, Oliver CK, Lippert LE, Rugg N, Joines AD, Gormas JF, Pratt PG, Silverstein EB, and Greenwalt TJ (2003) Twelve-week RBC storage. Transfusion 43:867-872.
13. Hillman RS and Finch CA (1967) Erythropoiesis: normal and abnormal. Semin Hematol 4:327-336.
14. Hoffman R, Benz EJ Jr., Shattil SJ, Furie B, Cohen HJ, Silberstein LE, and McGlave P (2005) Hematology: Basic Principles and Applications, 4th ed, Elsevier, Philadelphia, PA.
15. Hutchinson MF and deHoog FR (1985) Smoothing noise data with spline functions. Numer Math 47:99-106.
16. Izak G (1977) Erythroid cell differentiation and maturation. Prog Hematol 10:1-41.
17. Krzyzanski W and Jusko WJ (2002) Multiple-pool cell lifespan model of hematologic effects of anticancer agents. J Pharmacokinet Pharmacodyn 29:311-337.
18. Krzyzanski W, Jusko WJ, Wacholtz MC, Minton N, and Cheung WK (2005) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. Eur J Pharm Sci 26:295-306.
19. Krzyzanski W, Woo S, and Jusko WJ (2006) Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans. J Pharmacokinet Pharmacodyn 33:125-166.
20. Landaw SA (1988) Factors that accelerate or retard red blood cell senescence. Blood Cells 14:47-67.
21. Lin JC, Strauss RG, Kulhavy JC, Johnson KJ, Zimmerman MB, Cress GA, Connolly NW, and Widness JA (2000) Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 106:E19.
22. Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, de Grip WJ, Bos HJ, and Bosman GJ (2008) Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 48:1478-1485.
23. Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, and Widness JA (2005) Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 25:21-25.
24. Madsen LP, Rasmussen MK, Bjerregaard LL, Nøhr SB, and Ebbesen F (2000) Impact of blood sampling in very preterm infants. Scand J Clin Lab Invest 60:125-132.
25. McKenzie SB (1988) Textbook of Hematology, Lea & Febiger, Philadelphia, PA.
26. Meibohm B, Läer S, Panetta JC, and Barrett JS (2005) Population pharmacokinetic studies in pediatrics: issues in design and analysis. Aaps J 7:E475-E487.
27. Moritz KM, Lim GB, and Wintour EM (1997) Developmental regulation of erythropoietin and erythropoiesis. Am J Physiol 273:R1829-R1844.
28. Ohlsson A and Aher SM (2006) Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3:CD004863.
29. Roback JD, Combs MR, Grossman BJ and Hillyer CD (2008) Technical manual, 16th ed, American Association of Blood Banks, Bethesda, MD.
30. Savage VM, Gillooly JF, Woodruff WH, West GB, Allen AP, Enquist BJ, and Brown JH (2004) The predominance of quarter-power scaling in biology. Funct Ecol 18:257-282.
31. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, Gould SA, Harrison CR, Milam JD, Moise KJ Jr, et al. (1998) Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 122:130-138.
32. Sisson TR, Lund CJ, Whalen LE, and Telek A (1959) The blood volume of infants. I. The full-term infant in the first year of life. J Pediatr 55:163-179.
33. Strauss RG (1995) Red blood cell transfusion practices in the neonate. Clin Perinatol 22:641-655.
34. Strauss RG (2008) How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion 48:209-217.
35. Strauss RG, Mock DM, Widness JA, Johnson K, Cress G, and Schmidt RL (2004) Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 44:871-876.
36. Trudnowski RJ and Rico RC (1974) Specific gravity of blood and plasma at 4 and 37 degrees C. Clin Chem 20:615-616.
37. Usher R and Lind J (1965) Blood volume of the newborn premature infant. Acta Paediatr Scand 54:419-431.
38. Veng-Pedersen P (1977) Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5:513-531.
39. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, and Stevenson DK (2005) Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 115:1299-1306.
40. Widness JA, Schmidt RL, Veng-Pedersen P, Modi NB, and Sawyer ST (1992) A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies. J Lab Clin Med 119:285-294.